首页> Health technology assessment (Winchester, England)> Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation.

Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation.

导出 OA

翻译打印收藏纠错

第一作者： Isla S,Mackenzie

第一单位： MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.

作者： Isla S,Mackenzie ^[1] ; Christopher J,Hawkey ^[2] ; Ian,Ford ^[3] ; Nicola,Greenlaw ^[3] ; Filippo,Pigazzani ^[1] ; Amy,Rogers ^[1] ; Allan D,Struthers ^[1] ; Alan G,Begg ^[1] ; Li,Wei ^[4] ; Anthony J,Avery ^[5] ; Jaspal S,Taggar ^[5] ; Andrew,Walker ^[6] ; Suzanne L,Duce ^[1] ; Rebecca J,Barr ^[1] ; Jennifer S,Dumbleton ^[2] ; Evelien D,Rooke ^[1] ; Jonathan N,Townend ^[7] ; Lewis D,Ritchie ^[8] ; Thomas M,MacDonald ^[1] ; ALL-HEART Study Group

作者单位： MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK. ^[1] Nottingham Digestive Diseases Centre, University of Nottingham, Nottingham, UK. ^[2] The Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK. ^[3] School of Pharmacy, University College London, London, UK. ^[4] Centre for Academic Primary Care, School of Medicine, University of Nottingham, Nottingham, UK. ^[5] Salus Alba, Glasgow, UK. ^[6] Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. ^[7] Academic Primary Care, University of Aberdeen, Aberdeen, UK. ^[8]